EMA |
European Medicines Agency |
COVID-19 |
coronavirus disease 2019 |
DF |
deferoxamine |
DFRA |
deferasirox |
EDTA |
ethylenediaminetriacetic acid |
FDA |
Food and Drug Administration (USA) |
HIF |
Hypoxia-inducible factor |
ICOC |
International Committee on Chelation |
IDA |
iron deficiency anemia |
L1 |
deferiprone |
MRI |
magnetic resonance imaging |
NDRG |
1N-MYC downstream-regulated gene-1 |
NBIA |
neurodegeneration with brain iron accumulation |
PKAN |
Pantothenate-kinase-associated neurodegeneration |
STEAP4 |
six transmembrane epithelial antigen of prostate, family member 4 protein |